Managing Multiple TB Diagnostic Methods Under One Quality System
Tuberculosis laboratories often combine several diagnostic approaches: smear microscopy, culture, nucleic acid amplification, line probe assays, drug susceptibility testing, and rapid molecular platforms. Each method has different equipment, workflow, biosafety requirements, sources of error, and reporting timelines. Managing them effectively requires more than writing separate standard operating procedures.
A unified quality management system gives the laboratory a common structure while allowing method-specific controls where they are needed. The goal is to make quality consistent across testing areas without forcing every process into an identical format. The GLI Quality Tool supports this work through a four-phase roadmap aligned with twelve Quality Systems Essentials, including personnel, equipment, documents, assessment, safety, and continual improvement.
The strongest approach connects technical procedures to shared laboratory policies. Specimen identification, staff authorization, environmental controls, result verification, incident reporting, and corrective action should work the same way across platforms. Method-specific instructions can then address the scientific and operational differences within that framework.
Build One Quality Structure
Start by defining the laboratory’s quality policy, scope, responsibilities, and reporting lines. The scope should name every TB diagnostic service covered by the system, including testing performed at satellite sites or through referral arrangements. This prevents newer technologies from operating outside established quality oversight.
A quality manager or designated quality focal person should coordinate the system, while section leaders remain accountable for daily technical performance. Responsibilities should be documented in job descriptions, authorization records, and workflow charts. A staff member who is competent to perform smear microscopy should not automatically be considered competent for molecular testing or culture work.
The same document-control rules should apply to all methods. Each procedure needs an approved title, version number, effective date, review date, and authorization record. Obsolete versions must be removed from work areas and electronic folders. A central register can show which documents apply to which method, specimen type, instrument, and testing location.
Map Risks Across Methods
A method comparison is a practical starting point for identifying risks. List each test from specimen receipt to result release, then record the critical steps, required resources, possible failures, and controls. This reveals shared vulnerabilities, such as poor labeling, unsuitable specimens, transcription errors, and delayed reporting.
The risk assessment should also capture differences between methods. Smear microscopy may be affected by staining quality and reader variation. Culture requires strict contamination control, prolonged incubation, and appropriate biosafety measures. Molecular testing may be vulnerable to inhibition, contamination between areas, cartridge storage problems, or software and connectivity failures.
Use risk-based thinking to decide where controls must be identical and where they must be tailored. For example, patient identification and result authorization should follow one laboratory-wide policy, while internal quality control materials and acceptance criteria will vary by assay. A risk register should identify the responsible person, preventive control, monitoring activity, and action required when performance falls outside limits.
Specimen pathways deserve particular attention. If one specimen can be tested by several methods, define the order of testing, minimum volume, aliquoting rules, storage conditions, referral requirements, and rejection criteria. This reduces the chance that one section consumes material needed for another test or that repeated handling compromises safety and result reliability.
Standardize Documents And Competence
A common document hierarchy makes a complex service easier to control. At the top are the quality manual and laboratory-wide policies. Beneath them sit process procedures, method-specific SOPs, forms, logs, worksheets, equipment instructions, and external reference documents. Staff should be able to distinguish controlled documents from personal notes or unofficial copies.
Use consistent templates for SOPs, nonconformity records, equipment maintenance logs, temperature records, and training assessments. The technical content will differ, but the format should make essential information easy to find. Every method-specific SOP should cover purpose, scope, responsibilities, safety, specimens, reagents, equipment, procedure, quality control, interpretation, reporting, limitations, troubleshooting, and records.
Competence must be assessed separately for each authorized activity. A structured program can include initial training, direct observation, examination of known samples, review of worksheets, result interpretation, and periodic reassessment. Competence records should show the method, instrument or platform, date assessed, assessor, findings, and authorization decision.
Cross-training can improve resilience, especially when staffing is limited, but it should never replace documented authorization. A staff member may be competent in specimen reception and microscopy while still requiring supervised practice for a molecular platform. Refresher training is also necessary after major instrument changes, revised algorithms, recurring errors, or extended absence from a testing activity.
| Quality system area | Shared laboratory control | Method-specific control | Evidence to retain |
|---|---|---|---|
| Specimen management | Identification, acceptance, rejection, and traceability rules | Volume, transport, storage, and preparation requirements | Reception log, rejection record, specimen tracking |
| Personnel | Training policy, authorization process, and safety orientation | Assay and instrument competence | Training file, observation checklist, authorization list |
| Equipment | Purchase, maintenance, service, and failure reporting | Calibration, verification, software, and temperature limits | Asset register, maintenance log, verification report |
| Quality control | Review, escalation, and documentation of failures | Controls, targets, runs, and acceptance criteria | QC charts, run records, action records |
| Results and records | Verification, release, confidentiality, and retention | Interpretation rules, flags, and reporting comments | Worksheets, electronic audit trail, reports |
| Assessment | Internal audit, management review, and improvement cycle | Technical performance review and method comparison | Audit reports, indicators, meeting minutes |
Control Equipment And Results
Multiple diagnostic methods create a larger equipment network. The laboratory should maintain an inventory that includes instruments, biosafety cabinets, refrigerators, freezers, incubators, microscopes, computers, printers, uninterruptible power supplies, and temperature-monitoring devices. Each item needs an identifier, location, responsible person, maintenance schedule, and status.
Before introducing a new platform, verify that the laboratory has the infrastructure, utilities, environmental conditions, supplies, connectivity, and technical capacity required to operate it reliably. Installation, method verification, and acceptance testing should be documented before patient testing begins. Changes to instruments, reagent lots, software, or testing algorithms should be evaluated through a controlled change process.
Quality control data should be reviewed at the level where decisions are made. Section staff can monitor daily controls, while the quality manager reviews trends across methods. Repeated invalid results, contamination, declining smear proficiency, unexpected positivity rates, or stock-related interruptions may signal a system problem rather than an isolated technical error.
Result management must protect the complete chain from raw observation to final report. Define who checks instrument output, who resolves flags, who authorizes results, and how amended reports are issued. Where several methods are used for the same patient, the laboratory information system or manual record should make the relationship between specimens and results clear.
Prioritize Daily Operational Controls
A practical daily routine helps turn written procedures into consistent behavior:
- Review environmental, temperature, equipment, and safety records before testing begins.
- Confirm that current SOPs, reagents, controls, forms, and personal protective equipment are available.
- Check pending specimens and results so that urgent or high-risk work is not overlooked.
- Escalate QC failures, instrument problems, contamination events, and reporting delays promptly.
- Record deviations at the time they occur rather than reconstructing events later.
Daily huddles can connect sections that otherwise work separately. A short meeting may cover staffing, instrument status, reagent supply, biosafety concerns, pending maintenance, referral testing, and unusual results. Shared indicators such as rejection rates, invalid test rates, turnaround time, contamination, stock-outs, and amended reports help managers see how the full service is performing.
The laboratory should also define continuity arrangements. These may include referral pathways during instrument downtime, backup power, alternative testing platforms, reserve reagents, emergency contacts, and communication procedures for clinicians. Continuity plans should be tested periodically so staff know what to do when a method becomes temporarily unavailable.
Investigate Incidents And Corrective Action
An incident may affect one method while exposing a weakness in the wider system. A mislabeled specimen could result from reception training, workload, workspace design, or unclear forms. A contaminated culture may involve technique, airflow, equipment maintenance, or supply quality. Investigations should therefore look beyond individual blame and examine the process that allowed the error.
Use a consistent incident and nonconformity process across all testing areas. The record should describe what happened, when and where it occurred, affected specimens or results, immediate containment, risk to patients or staff, investigation findings, root cause, corrective action, responsible person, deadline, and effectiveness review. Laboratories can adapt this corrective action form to make incident follow-up more consistent.
Immediate action may include stopping a run, quarantining reagents, recalling a report, repeating testing, notifying a clinician, or referring specimens. Corrective action addresses the cause, while preventive controls reduce the chance of recurrence. Closing a record should require evidence that the action was completed and that performance improved.
Trends across methods are especially valuable. Several small errors involving result transcription, delayed maintenance, or incomplete QC review may indicate a shared process weakness. A quarterly review of incidents and corrective actions can reveal where the laboratory needs retraining, workflow redesign, additional resources, or a policy change.
Use Assessment To Drive Improvement
Internal audits should examine both the common quality framework and the technical details of each method. Auditors can follow a specimen through reception, testing, review, reporting, and record storage. This process-based approach often identifies gaps that a document-only review would miss.
External quality assessment and proficiency testing provide independent evidence of analytical performance. Results should be reviewed promptly, and unsatisfactory performance should trigger documented investigation. When an external scheme is unavailable, laboratories can use blinded rechecking, split-sample comparison, reference materials, or exchanges with a qualified partner where appropriate.
Management review brings evidence together for decisions. The agenda may include quality indicators, audit findings, EQA results, incidents, complaints, staffing, equipment, supply continuity, biosafety, training, and progress on corrective actions. Decisions should identify resources, owners, deadlines, and measures of success.
The GLI Quality Tool can help laboratories organize this evidence across its phased roadmap and Quality Systems Essentials. Laboratories preparing for an external review can also use this WHO accreditation preparation resource to connect routine quality records with accreditation expectations. Sharing practical experiences through share your feedback can help strengthen guidance for laboratories working in varied resource settings.
A unified system does not require every TB diagnostic method to operate identically. It requires every method to be governed by clear responsibilities, controlled documents, competent personnel, reliable equipment, traceable records, risk-based monitoring, and a repeatable improvement cycle. Begin by mapping the full testing pathway, then use the GLI Quality Tool resources to organize priorities, document evidence, and strengthen oversight across the laboratory.